• Headquartered in Madison, WI

• Founded in 2015

• Overview:

BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the proprietary technology of directed differentiation of human stem cells (including induced pluripotent stem cells) to highly enriched subclasses of neurons. BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. From motor neurons to cortical sub-types, we can provide specific models for both disease or normal drug screening. We are dedicated to delivering the highest quality products from both our off-the-shelf neurons as well as any custom service projects.

BrainXell also aims to develop stem cell therapy for neurological injuries and diseases through collaboration with pharmaceutical and healthcare industry. BrainXell’s goal is to make our brain healthy and well.

• Distributors:

  BrainXell serves neuroscientists around the world. We provide products in North America and many other countries directly. Our distribution partners in Europe and Japan are listed below.

  Belgium, Netherlands, and Luxembourg
  Bio-Connect B.V.
  Phone: +31 (0)26-326-4450
  Email: info@bio-connect.nl / orders@bio-connect.nl
  Web: www.bio-connect.nl

  Germany, Austria, and Switzerland
  BIOZOL Diagnostica Vertrieb GmbH
  Phone: +49 (089) 3799 666-6
  Email: bestellung@biozol.de / info@biozol.de
  Web: www.biozol.de

  France, Italy, Denmark, Sweden, Finland, Norway, Iceland, Ireland and Morocco
  CliniSciences
  Phone: +33 9 77 40 09 09 / +39 06 94 80 56 71
  Email: info@clinisciences.com / italia@clinisciences.com
  Web: www.clinisciences.com

  Spain
  Quimigen
  Phone: +34 91 675 0700
  Email: pedidos@quimigen.com
  Web: www.quimigen.com

  Japan
  Funakoshi Co., Ltd.
  Phone: +81 3 5684 1620
  Email: reagent@funakoshi.co.jp
  Web: www.funakoshi.co.jp